cystic
fibrosi
cf
pseudomona
aeruginosa
pa
colon
lung
lead
chronic
inflamm
bronchial
epithelium
chac
glutathionespecif
mrna
differenti
express
primari
human
airway
epitheli
cell
bronchi
haecb
patient
cf
healthi
patient
baselin
upon
infect
pa
degrad
glutathion
associ
er
stress
apoptosi
pathway
studi
examin
role
inflammatori
respons
apoptosi
lung
epitheli
cell
first
confirm
revers
transcript
quantit
polymeras
chain
reaction
mrna
overexpress
haecb
patient
without
cf
compar
express
haecb
patient
cf
upon
pa
pak
strain
infect
moreov
pa
virul
factor
lp
flagellin
shown
induc
express
cell
patient
without
cf
use
lung
epitheli
cell
found
lpsinduc
mrna
express
perkindepend
involv
addit
use
small
interf
rna
show
reduc
express
context
lp
flagellin
stimul
associ
modul
inflammatori
marker
alter
signal
final
show
pa
abl
induc
apoptosi
cell
result
suggest
involv
regul
inflamm
bronchial
cell
pa
infect
may
explain
excess
inflamm
present
respiratori
tract
patient
cf
cystic
fibrosi
cf
pseudomona
aeruginosa
pa
colon
lung
lead
chronic
inflamm
bronchial
epithelium
chac
glutathionespecif
mrna
differenti
express
primari
human
airway
epitheli
cell
bronchi
haecb
patient
cf
healthi
patient
baselin
upon
infect
pa
degrad
glutathion
associ
er
stress
apoptosi
pathway
studi
examin
role
inflammatori
respons
apoptosi
lung
epitheli
cell
first
confirm
revers
transcript
quantit
polymeras
chain
reaction
mrna
overexpress
haecb
patient
without
cf
compar
express
haecb
patient
cf
upon
pa
pak
strain
infect
moreov
pa
virul
factor
lp
flagellin
shown
induc
express
cell
patient
without
cf
use
lung
epitheli
cell
found
lpsinduc
mrna
express
perkindepend
involv
addit
use
small
interf
rna
show
reduc
express
context
lp
flagellin
stimul
associ
modul
inflammatori
marker
alter
signal
final
show
pa
abl
induc
apoptosi
cell
result
suggest
involv
regul
inflamm
bronchial
cell
pa
infect
may
explain
excess
inflamm
present
respiratori
tract
patient
cf
keyword
cystic
fibrosi
bronchial
epithelium
pseudomona
aeruginosa
inflamm
chac
glutathionespecif
er
stress
introduct
cystic
fibrosi
cf
common
sever
autosom
recess
genet
diseas
caucasian
popul
caus
mutat
cf
transmembran
conduct
regul
cftr
gene
lung
injuri
predomin
lead
caus
morbid
mortal
cf
patient
airway
cftr
dysfunct
lead
alter
mucociliari
clearanc
impair
innat
immun
host
defens
result
chronic
bacteri
infect
inflamm
lead
degrad
lung
epithelium
progress
lung
damag
cf
patient
pseudomona
aeruginosa
pa
lead
caus
chronic
pulmonari
infect
airway
adult
cf
pa
colon
induc
strong
inflammatori
respons
cf
patient
particularli
neutrophil
accumul
hypersecret
inflammatori
cytokin
lung
epithelium
play
essenti
role
fight
infect
orchestr
innat
immun
lung
epitheli
cell
suffici
gener
innat
protect
immun
respons
mice
infect
pa
cf
establish
chronic
pulmonari
infect
pa
link
alter
epitheli
cell
respons
allow
establish
adequ
defens
system
previous
show
respons
inde
differ
compar
analysi
transcriptom
signatur
primari
cf
noncf
bronchial
epitheli
cell
pa
infect
identifi
sever
upand
downregul
mrna
cf
cell
compar
noncf
cell
suggest
gene
may
involv
exacerb
inflammatori
respons
pa
found
cf
patient
among
dysregul
mrna
chac
glutathionespecif
show
dramat
differenti
express
noncf
cf
cell
baselin
pa
infect
identifi
mammalian
cell
first
time
new
compon
unfold
protein
respons
upr
pathway
upr
pathway
induc
respons
er
stress
due
presenc
misfold
protein
er
lumen
upr
consist
three
pathway
initi
inositolrequir
enzym
eukaryot
translat
initi
factor
kinas
perk
activ
transcript
factor
atf
three
pathway
allevi
er
stress
decreas
protein
synthesi
facilit
protein
fold
increas
protein
degrad
induc
perk
pathway
downstream
proapoptot
factor
dna
damageinduc
transcript
also
call
chop
describ
necessari
suffici
induc
marker
apoptosi
particularli
cleavag
apoptot
factor
poli
adpribos
polymeras
parp
moreov
degrad
glutathion
cytosol
mammalian
cell
activ
variou
studi
shown
link
er
stress
inflamm
context
cf
atyp
activ
upr
pathway
observ
result
er
stress
potenti
inflammatori
respons
moreov
upr
implic
regul
cytokin
product
bacteri
infect
role
interplay
er
stress
inflamm
context
pa
infect
never
investig
accordingli
studi
hypothes
may
play
role
regul
inflammatori
process
induc
pa
infect
apoptosi
pa
serotyp
lp
staurosporin
tobramycin
dmso
sigmaaldrich
saintquentin
fallavi
franc
purifi
pa
flagellin
ngml
invivogen
san
diego
ca
usa
tunicamycin
tm
inhibitor
calbiochem
merck
millipor
molsheim
franc
rockvil
md
usa
luciferas
cell
panom
fremont
ca
usa
grown
previous
primari
haecb
cf
patient
healthi
donor
tabl
commerci
obtain
epithelix
plan
le
ouat
switzerland
cultur
previous
cell
seed
differ
plate
tpp
techno
plastic
product
trasadingen
switzerland
reach
confluenc
incub
overnight
dmem
contain
fb
antibiot
stimul
medium
free
antibiot
pa
wt
pak
strain
mutant
flic
delet
flagellin
doubl
mutant
pscf
xcpq
delet
type
ii
iii
secret
system
use
grown
previous
od
measur
nm
adjust
give
desir
moi
moi
verifi
serial
dilut
bacteri
suspens
plate
lb
agar
supplementari
figur
cell
seed
haecb
plate
infect
pa
cultur
medium
without
antibiot
stimul
supernat
collect
centrifug
g
min
remov
bacteria
clinic
strain
pa
isol
accord
standard
procedur
microbiolog
depart
stantoin
hospit
pari
franc
sputum
patient
dilut
vv
predilut
digesteur
eurobio
courtaboeuf
franc
vortex
incub
min
room
temperatur
aliquot
plate
differ
select
media
day
c
aerob
condit
pa
isol
drigalski
agar
plate
identif
confirm
mass
spectrometri
maldibiotyp
brucker
franc
stenotrophomona
maltophilia
freshli
isol
cf
patient
identif
confirm
mass
spectrometri
maltophilia
staphyloccocu
aureu
newman
strain
cultur
use
protocol
pa
describ
rna
isol
use
nucleospin
rnaprotein
kit
macherey
nagel
duren
germani
rt
perform
use
highcapac
cdna
kit
appli
biosystem
foster
citi
ca
usa
realtim
qpcr
perform
abi
steponeplu
use
taqman
fast
univers
pcr
master
mix
appli
biosystem
taqman
probe
gapdh
cdna
templat
rel
quantif
amount
target
gene
normal
express
gapdh
rel
control
cell
use
calibr
calcul
use
ct
method
total
protein
extract
use
nucleospin
rnaprotein
kit
macherey
nagel
equal
amount
protein
reduc
sizesepar
sdspolyacrylamid
gel
transfer
nitrocellulos
membran
invitrogen
membran
block
milk
tbstween
incub
specif
primari
antibodi
sigmaaldrich
parp
cell
signal
technolog
cst
danver
usa
cst
cleav
cst
phosphoand
total
cst
sigmaaldrich
antibodi
valid
overexpress
perform
plasmid
previous
shown
express
monitor
live
cell
use
evo
cell
imag
system
thermo
fisher
scientif
luciferas
activ
cell
assay
luciferas
kit
promega
madison
wi
usa
accord
manufactur
protocol
fluostar
optima
luminomet
bmg
labtech
champigni
sur
marn
franc
differ
among
group
assess
statist
signific
use
prism
softwar
graphpad
softwar
la
jolla
ca
usa
indic
figur
legend
differ
p
consid
statist
signific
previou
transcriptom
analysi
identifi
one
differenti
express
mrna
human
airway
epitheli
cell
bronchi
haecb
patient
without
cf
pa
infect
inde
mrna
induc
haecb
noncf
patient
figur
figur
cf
cell
valid
differenti
express
qpcr
sampl
use
rnaseq
inde
baselin
observ
significantli
higher
express
noncf
cell
compar
cf
cell
expect
transcriptom
data
observ
upregul
mrna
express
h
pa
infect
noncf
cell
figur
pa
induc
express
noncf
cell
investig
pa
virul
factor
involv
studi
effect
two
wellknown
virul
factor
lp
flagellin
pa
haecb
cf
noncf
patient
cell
express
mrna
suffici
level
knockdown
experi
comparison
cell
supplementari
figur
notabl
h
stimul
lp
flagellin
induc
express
haecb
noncf
patient
similar
whole
bacteria
moi
h
induct
lp
flagellin
live
bacteria
found
haecb
cf
patient
figur
observ
similar
effect
lp
flagellin
express
cell
figur
valid
role
flagellin
express
use
mutant
pa
pak
strain
flic
flagellin
delet
observ
significantli
lower
increas
mrna
express
cell
stimul
flic
strain
wt
pak
strain
figur
also
test
doubl
mutant
pa
pak
strain
type
ii
iii
secret
system
delet
pscf
xcpq
mutant
induc
mrna
express
similar
wt
pak
strain
figur
differ
express
observ
flic
strain
due
differ
moi
sinc
equal
number
pa
coloni
found
lb
agar
supplementari
figur
subsequ
order
determin
whether
observ
upregul
restrict
laboratori
pak
strain
use
pa
strain
freshli
isol
differ
patient
cf
observ
clinic
isol
pa
also
abl
induc
mrna
express
cell
figur
effect
similar
pak
induct
highli
variabl
clinic
strain
use
may
reflect
differ
virul
strain
sinc
number
bacteria
use
stimul
similar
supplementari
figur
induct
pak
strain
also
highli
variabl
figur
like
due
variabl
inoculum
use
supplementari
figur
also
observ
induct
mrna
express
pak
higher
cell
haecb
figur
c
vs
figur
final
test
two
bacteri
speci
known
colon
airway
patient
cf
ie
aureu
maltophilia
use
similar
moi
observ
reduc
mrna
induct
cell
infect
aureu
maltophilia
compar
cell
infect
pa
concomitantli
induct
mrna
express
reduc
figur
differ
mrna
express
observ
aureu
maltophilia
caus
differ
moi
equal
number
coloni
found
lb
agar
supplementari
figur
next
examin
protein
express
respons
pa
stimul
consist
previou
report
indic
protein
unstabl
due
rapid
degrad
proteasom
cell
unabl
detect
endogen
protein
baselin
supplementari
figur
pa
infect
data
shown
addit
unabl
detect
protein
express
treat
cell
tunicamycin
known
induc
mrna
express
data
shown
detect
protein
level
either
overexpress
plasmid
cell
figur
cell
treat
least
proteasom
inhibitor
figur
shown
associ
perk
pathway
hypothes
induct
lp
pa
may
mediat
perk
therefor
use
perk
inhibitor
tunicamycin
tm
posit
control
figur
activ
perk
pathway
expect
compar
untreat
cell
lp
tm
induc
mrna
express
cell
treat
tm
perk
inhibitor
signific
decreas
mrna
express
compar
cell
treat
tm
alon
figur
howev
cell
treat
lp
perk
inhibitor
mrna
express
significantli
differ
cell
treat
lp
figur
hypothes
induct
lp
would
directli
pass
inde
observ
lp
abl
activ
sirna
inhibit
induct
figur
inhibit
express
sirna
associ
inhibit
induct
lp
figur
shown
play
role
apoptosi
therefor
investig
effect
pa
stimul
apoptosi
infect
cell
two
differ
moi
h
examin
level
cleav
parp
cleav
expect
observ
posit
control
staurosporin
induc
cleavag
parp
contrast
pa
induc
cleavag
parp
figur
parp
cleavag
observ
overexpress
plasmid
cell
figur
compon
er
stress
pathway
link
er
stress
inflammatori
respons
alreadi
describ
context
cf
therefor
investig
role
inflammatori
respons
induc
lp
flagellin
transfect
sirna
induc
around
reduct
mrna
express
figur
examin
differ
inflammatori
paramet
particularli
secret
expect
observ
lp
ngml
flagellin
combin
lpsflagellin
induc
signific
increas
secret
tend
increas
pge
secret
figur
stimul
condit
mrna
express
decreas
use
sirna
greater
signific
increas
secret
figur
pge
secret
figur
observ
contrast
presenc
sirna
observ
signific
inhibit
secret
figur
cell
stimul
lp
inhibit
flagellin
inhibit
combin
virul
factor
inhibit
obtain
similar
result
mrna
express
supplementari
figur
c
mrna
express
also
modul
similar
express
experiment
condit
detect
elisa
supplementari
figur
determin
whether
regul
inflammatori
paramet
involv
studi
phosphoryl
western
blot
cell
observ
lp
induc
signific
increas
phosphoryl
cell
h
stimul
figur
confirm
data
use
luciferas
cell
cell
inhibit
mrna
express
observ
sirna
transfect
data
shown
similar
cell
observ
lp
ngml
flagellin
combin
lpsflagellin
induc
signific
increas
secret
cell
transfect
sirna
compar
cell
transfect
sirna
control
figur
addit
expect
observ
lp
ngml
flagellin
combin
lpsflagellin
induc
signific
increas
activ
figur
experiment
condit
decreas
mrna
express
observ
even
greater
increas
activ
cell
stimul
lp
andor
flagellin
figur
detect
elisa
data
shown
independ
cftr
mutat
link
er
stress
cfrelat
inflamm
extens
studi
particularli
regard
inositolrequir
enzym
perk
data
express
mean
sem
independ
experi
statist
analysi
perform
use
analysi
varianc
follow
dunnett
multipl
comparison
test
control
group
ns
p
p
wilcoxon
test
sirna
ctrl
vs
sirna
group
p
p
p
p
pathway
previou
studi
identifi
mrna
one
highli
differenti
express
transcript
primari
bronchial
cell
cf
noncf
patient
infect
pa
also
found
cf
cell
exhibit
expect
excess
inflammatori
respons
includ
higher
product
recent
describ
new
compon
upr
perk
pathway
aim
evalu
whether
involv
modul
inflammatori
respons
induc
pa
lung
epitheli
cell
confirm
previou
transcriptom
data
show
mrna
overexpress
primari
noncf
epitheli
cell
compar
express
cf
cell
baselin
upon
pa
infect
addit
pa
two
virul
factor
lp
flagellin
respect
ligand
tolllik
receptor
tlr
abl
induc
transcript
level
bronchial
epitheli
cell
previous
shown
hek
cell
abl
detect
protein
express
treatment
suggest
involv
proteasom
pathway
stabil
protein
induct
mrna
express
observ
laboratori
strain
pak
also
freshli
isol
clinic
strain
interestingli
maltophilia
aureu
known
chronic
infect
cf
patient
abl
induc
mrna
express
similar
level
use
cellular
infect
model
transcriptom
studi
consist
shown
upregul
microorgan
includ
human
coronaviru
human
cytomegaloviru
tickborn
flavivirus
zika
viru
bacterium
mycoplasma
homini
studi
specif
role
investig
howev
essenti
embryon
lethal
observ
mice
delet
gene
studi
mrna
induct
lp
pa
relat
perk
activ
tm
depend
contrast
lp
e
coli
previous
shown
activ
perk
cell
notabl
shown
directli
recruit
independ
er
stress
human
monocyt
consist
result
anoth
er
stressassoci
molecul
recent
shown
upregul
sever
virul
factor
pa
includ
pyocyanin
apra
independ
perk
depend
taken
togeth
result
consist
emerg
evid
show
induct
upr
pathway
microorgan
reflect
er
stress
integr
part
immun
respons
tlr
pathway
fine
tune
immun
respons
upr
extens
studi
howev
contribut
regul
cytokin
product
bacteri
infect
well
understood
observ
inhibit
mrna
express
sirna
promot
express
secret
suggest
prevent
excess
inflammatori
respons
depend
pathway
result
consist
recent
studi
report
bronchial
epitheli
cell
undergo
er
stress
show
reduc
product
presenc
inflammatori
stimuli
inde
pretreat
bronchial
epitheli
cell
tm
shown
other
abl
increas
express
prevent
product
contrast
inhibit
mrna
express
sirna
inhibit
product
suggest
may
promot
express
result
consist
previou
studi
show
tm
promot
secret
bronchial
cf
defici
cell
stimul
flagellin
previou
work
demonstr
product
skin
cell
depend
chop
howev
chop
expect
upstream
pathway
explain
result
futur
studi
need
determin
pathway
affect
specif
lung
epitheli
cell
addit
role
upr
member
famili
abl
hydrolyz
glutathion
reduc
form
gsh
glutathion
wide
studi
owe
function
cftr
glutathion
transport
gsh
homeostasi
defect
cf
gsh
promot
oxid
stress
relat
inflamm
role
activ
relat
cellular
glutathion
homeostasi
observ
cytokin
regul
remain
determin
although
previou
studi
demonstr
level
glutathionerel
enzym
regul
cytokin
product
experi
pak
induc
apoptosi
cell
howev
cell
complet
resist
apoptosi
sinc
staurosporin
abl
induc
parp
cleavag
thu
although
induc
pa
suffici
induc
cell
apoptosi
conceiv
level
induct
may
low
promot
apoptosi
contrast
high
induct
use
overexpress
plasmid
led
induct
parp
cleavag
indic
cell
apoptosi
apoptosi
dysfunct
still
highli
controversi
cf
result
partli
consist
previou
studi
inde
even
pa
previous
shown
induc
apoptosi
lung
epitheli
cell
variabl
suscept
lung
epitheli
cell
observ
moreov
strain
pa
shown
induc
apoptosi
human
tracheal
cell
primari
nasal
epitheli
cell
polyp
bronchial
cell
resist
contrast
bronchial
cell
line
permiss
apoptosi
induc
pa
correct
cell
cell
recent
use
polar
lung
epitheli
cell
research
show
abl
induc
apoptosi
marker
activ
within
h
addit
effect
cftr
genotyp
apoptosi
lung
epitheli
cell
baselin
pa
infect
still
debat
may
depend
specif
marker
apoptosi
evalu
conclus
show
inhibit
bronchial
epitheli
cell
result
regul
inflammatori
mediat
moreov
induc
preferenti
normal
haecb
comparison
cf
haecb
respons
pa
virul
factor
lp
flagellin
thu
result
suggest
low
express
may
contribut
excess
inflamm
observ
cf
bronchial
epitheli
cell
pa
infect
thu
may
associ
exacerb
inflamm
character
lung
patient
cf
inflamm
complex
thought
critic
impact
cours
cf
lung
diseas
better
understand
link
infect
inflamm
thu
requir
develop
new
therapeut
lg
mc
vb
design
studi
